The Pandemic Proved the Need To Strengthen the Healthcare Infra

the latest tech news, global tech news daily, tech news today, startups, usa tech, asia tech, china tech, eu tech, global tech, in-depth electronics reviews, 24h tech news, 24h tech news, top mobile apps, tech news daily, gaming hardware, big tech news, useful technology tips, expert interviews, reporting on the business of technology, venture capital funding, programing language

The last couple of years has been a tough period for most industries due to the COVID-19 pandemic. Though for some industries, the pandemic created unbelievably golden opportunities to thrive in their field, for industries like healthcare, the pandemic has highlighted the structural gaps in the current healthcare system and the significance of digital health.

The Pandemic Proved the Need To Strengthen the Healthcare Infra
Pexels

Though the Indian government increased the healthcare budget by 137 per cent in the FY2021-22, the measures taken were to handle the situation at hand, and not a long-term investment to make healthcare future-proof.

the latest tech news, global tech news daily, tech news today, startups, usa tech, asia tech, china tech, eu tech, global tech, in-depth electronics reviews, 24h tech news, 24h tech news, top mobile apps, tech news daily, gaming hardware, big tech news, useful technology tips, expert interviews, reporting on the business of technology, venture capital funding, programing language

A resilient and inclusive medical infrastructure is essential for India to handle inevitable situations in the future that could be catastrophic like the COVID-19 pandemic. Here are a couple of budget expectations from our healthcare experts who are primarily focused on making healthcare available for everyone, including tier-III towns and rural regions.

Focus more on digital health

Global Tech News Daily

Though not ready, the healthcare industry embraced technology innovations at scale during the COVID pandemic to contain the spread of the contagion. For example, the use of telehealth skyrocketed during the pandemic.Stats from a survey conducted by Statista between March and May 2020, show that nearly 85 per cent of clinicians used digital platforms and teleconsultation during the pandemic, in which 80 per cent of teleconsultation services were from first-time users.For years, ‘distance’ has been a key barrier to accessing timely healthcare for millions across the globe. But, during the pandemic, distance was the only means of containing the spread. With technology, the healthcare industry can shrink and increase distance at the same time while enhancing system preparedness and responsiveness for any situation, be it an epidemic or a pandemic.

A real-time example of impact created by digital health is Arogya Setu, primarily a mobile application developed by the National Informatics Centre under the ministry of electronics and information technology to aid the government in the fight against COVID-19.

Global Tech News Daily

We see that several such digital health platforms are being created indigenously and have the potential to significantly improve both the reach and quality of healthcare to the Indian population. Any government incentives to support startups building digital solutions would help bring more patient data online helping with efficient distribution of healthcare services.

Also, investing in digital health will help India meet the doctor to population ratio recommended by WHO (World Health Organization), in every state, particularly in public healthcare sectors.

WHO recommends a doctor to population ratio of 1:1000. Only 11 among the 28 states in India have met the WHO recommended doctor to population ratio. India’s public healthcare system functions at a dismal ratio of 0.08:1000.

Western nations have already started investing in digital health initiatives. For instance, Australia has invested $870.5 million to modernize the health system and ensure interoperability within the digital health infrastructure. With digital health, India can make immense improvements in healthcare access, delivery, efficiency and productivity of healthcare professionals.

Reduced GST on healthcare products

Besides accessibility, healthcare services and products must be affordable, particularly in a nation like India, which has around 84 million people (which is around 6 per cent of the total population) living in extreme poverty conditions. According to estimates, due to the sudden outbreak of COVID-19, an additional 150-199 million people will be pushed into poverty in 2021-2022.

One way to make healthcare products and services affordable for the masses is reducing GST on healthcare infrastructure products and not just services. Also, reductions in import duty and simplification of FDI (foreign direct investment) norms will help in making healthcare services and products more affordable.

Allocate budget for trauma centers in PHCs and CHCs

Including trauma systems in PHCs (primary health centers) and CHCs (community health centers) is a costly process but an essential one for India, a country that has the youngest workforce but with increasing incidence of chronic illnesses. In fact, healthcare experts are looking forward to a sharp rise in healthcare expenses in the current as well as the coming decade. Emerging technologies like AI can help sharply cut expenses and time for identifying traumatic cases that need immediate attention.

Hence, the government should consider allocating a budget for including trauma centers equipped with machines powered by advanced technologies like AI (for example, AI-enabled PACS) in PHCs and CHCs.

Extend National Health Protection Scheme

Further, healthcare experts want the government to consider increasing healthcare expenditure above 2.5 per cent of the GDP. Experts also look forward to the government extending its National Health Protection Scheme to migrant workers and the BPL population. 

According to a recent survey conducted by NSS (National Sample Survey) on health expenditure coverage under the government as well as private insurance providers, 85.9 per cent of rural Indians don’t have any health expenditure coverage.

News Related

OTHER NEWS

Triton International (TRTN) Gains As Market Dips: What You Should Know

Triton International (TRTN) closed the most recent trading day at $61.10, moving +0.31% from the previous trading session. This change outpaced the S&P 500’s 0.37% loss on the day. – ... Read more »

Asbury Automotive Group (ABG) Dips More Than Broader Markets: What You Should Know

Asbury Automotive Group (ABG) closed the most recent trading day at $151.49, moving -0.81% from the previous trading session. This move lagged the S&P 500’s daily loss of 0.37%. – ... Read more »

Cushman & Wakefield (CWK) Gains As Market Dips: What You Should Know

Cushman & Wakefield (CWK) closed the most recent trading day at $21.46, moving +1.18% from the previous trading session. This change outpaced the S&P 500’s 0.37% loss on the day. ... Read more »

Wesco International (WCC) Gains As Market Dips: What You Should Know

Wesco International (WCC) closed at $121.43 in the latest trading session, marking a +1.57% move from the prior day. The stock outpaced the S&P 500’s daily loss of 0.37%. – ... Read more »

Big Tech Looks To Buy Beaten Down Innovation-Fueled Entrants

The recent rate-fueled valuation crush among next-gen tech has created some ripe acquisition opportunities for cash-rich mega-cap tech. After rapidly deteriorating investor sentiment, Peloton PTON is the latest acquisition target, ... Read more »

HP (HPQ) Stock Moves -0.29%: What You Should Know

In the latest trading session, HP (HPQ) closed at $37.49, marking a -0.29% move from the previous day. This change was narrower than the S&P 500’s daily loss of 0.37%. ... Read more »

One Stop Systems, Inc. (OSS) Flat As Market Sinks: What You Should Know

In the latest trading session, One Stop Systems, Inc. (OSS) closed at $4.05, marking no change from the previous day. This change was narrower than the S&P 500’s daily loss ... Read more »

Luminar Technologies, Inc. (LAZR) Gains As Market Dips: What You Should Know

Luminar Technologies, Inc. (LAZR) closed at $14.84 in the latest trading session, marking a +0.27% move from the prior day. The stock outpaced the S&P 500’s daily loss of 0.37%. ... Read more »

Buckle (BKE) Gains As Market Dips: What You Should Know

Buckle (BKE) closed at $37.24 in the latest trading session, marking a +1.36% move from the prior day. This change outpaced the S&P 500’s 0.37% loss on the day. – ... Read more »

AutoNation (AN) Dips More Than Broader Markets: What You Should Know

In the latest trading session, AutoNation (AN) closed at $103.57, marking a -0.46% move from the previous day. This change lagged the S&P 500’s 0.37% loss on the day. – ... Read more »

FuboTV Inc. (FUBO) Stock Moves -0.3%: What You Should Know

fuboTV Inc. (FUBO) closed at $10.07 in the latest trading session, marking a -0.3% move from the prior day. This change was narrower than the S&P 500’s 0.37% loss on ... Read more »

Fiverr International (FVRR) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Fiverr International (FVRR) closed at $81.01, marking a -0.52% move from the previous day. This change lagged the S&P 500’s daily loss of 0.37%. – ... Read more »

Sterling Construction (STRL) Gains As Market Dips: What You Should Know

Sterling Construction (STRL) closed at $27.51 in the latest trading session, marking a +1.63% move from the prior day. The stock outpaced the S&P 500’s daily loss of 0.37%. – ... Read more »

Boise Cascade (BCC) Gains As Market Dips: What You Should Know

Boise Cascade (BCC) closed at $77.20 in the latest trading session, marking a +0.69% move from the prior day. The stock outpaced the S&P 500’s daily loss of 0.37%. – ... Read more »

CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $62.36, marking a +0.76% move from the previous day. This move outpaced the S&P 500’s daily loss of 0.37%. ... Read more »

Bausch Health (BHC) Dips More Than Broader Markets: What You Should Know

Bausch Health (BHC) closed the most recent trading day at $24.39, moving -0.53% from the previous trading session. This move lagged the S&P 500’s daily loss of 0.37%. – Zacks ... Read more »

ETF Strategies to Consider for February as Fed's Rate Hike Nears

Wall Street has been mostly kind to investors so far in February after a tough January. Market participants are upbeat about improving U.S. economic conditions as reflected by encouraging fourth-quarter ... Read more »

Bank of Nova Scotia (BNS) Gains As Market Dips: What You Should Know

Bank of Nova Scotia (BNS) closed at $73.75 in the latest trading session, marking a +0.78% move from the prior day. This move outpaced the S&P 500’s daily loss of ... Read more »

Fox (FOXA) to Report Q2 Earnings: What's in the Offing?

Fox FOXA is set to report second-quarter fiscal 2022 results on Feb 9.For the quarter, the company’s current Zacks Consensus Estimate for earnings is pegged at breakeven against a loss ... Read more »

Generac Holdings (GNRC) Gains As Market Dips: What You Should Know

In the latest trading session, Generac Holdings (GNRC) closed at $279.97, marking a +0.01% move from the previous day. This move outpaced the S&P 500’s daily loss of 0.37%. – ... Read more »

Spirit And Frontier Announce $6.6 Billion Merger

Spirit Airlines Incorporated (NYSE:SAVE) and Frontier Group Holdings Inc (NASDAQ:ULCC) have announced a $6.6 billion merger to create one of the largest low-cost airlines in the U.S. The new airline ... Read more »

First Trust Energy AlphaDEX Fund (FXN) Hits a 52-Week High

The First Trust Energy AlphaDEX Fund FXN is probably a suitable pick for investors looking for momentum. FXN hit a 52-week high and is up 59.6% from its 52-week low ... Read more »

Meta Threatens To Close Facebook And Instagram In Europe Over Data Scramble

In a document filed with the U.S. Securities and Exchange Commission (SEC), Meta Platforms Inc (NASDAQ:FB) has warned it could be forced to close Facebook and Instagram in Europe if ... Read more »

How a To-Don't List Can Help You Achieve Your Goals

To-do lists are helpful tools for many people, but they can quickly take over our lives, making daily living feel like just another item to cross off of a never-ending ... Read more »

Immunovant (IMVT) Reports Wider-Than-Expected Loss in Q3

Immunovant, Inc. IMVT reported a net loss of 36 cents per share in the third quarter of fiscal 2022 (ended Dec 31, 2021), wider than the Zacks Consensus Estimate of ... Read more »

Buckle's (BKE) Sales Run Continues in January, Comps Gain 4.2%

The Buckle, Inc. BKE looks well poised on the back of its robust strategic efforts, including strength in e-commerce business and an impressive sales trend. BKE has been putting up ... Read more »

6 Best-Leveraged ETF Areas of Last Week

Wall Street put up a moderate show last week with the S&P 500 (up 1.6%), the Dow Jones (up 1.1%), the Nasdaq Composite (up 2.4%) and the Russell 2000 (up ... Read more »

Interpublic (IPG) to Report Q4 Earnings: What's in the Cards?

The Interpublic Group of Companies, Inc. IPG is scheduled to report fourth-quarter 2021 results on Feb 10, before the opening bell. – Zacks Let’s check out how things have shaped ... Read more »

Mednax (MD) Buys Night Lite Pediatrics to Boost Portfolio

Mednax, Inc. MD and its affiliated practices Pediatrix Medical Group recently acquired Night Lite Pediatrics, LLC in Orlando, FL. Night Lite is a private 13-clinic pediatric urgent care practice. The ... Read more »

Best Growth Stocks to Buy for February 7th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, February 7th: – Zacks Apple AAPL: This company whose business primarily runs around its ... Read more »

Gol Linhas (GOL) Stock up 16.2% in a Month: More Upside Left?

Shares of Gol Linhas GOL have displayed an uptrend on the bourses over the past month, gaining 16.2% against its industry’s 3.1% decline. – Zacks Image Source: Zacks Investment Research ... Read more »

Top Research Reports for Bank of America, Coca-Cola & salesforce

Monday, February 7, 2022 The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Bank ... Read more »

Sanofi's (SNY) Enjaymo Gets FDA Nod For Rare Blood Disorder

Sanofi SNY announced that the FDA has approved its monoclonal antibody, Enjaymo (sutimlimab-jome), to decrease the need for red blood cell transfusion due to hemolysis in adult patients with cold ... Read more »

The Zacks Analyst Blog Highlights: Alphabet, T-Mobile US, Advanced Micro Devices, Mondelez International and Chubb

For Immediate Release Chicago, IL – February 7, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ... Read more »

Why Mid-America Apartment Communities (MAA) is a Great Dividend Stock Right Now

Whether it’s through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you’re an income investor, your primary focus is ... Read more »

On Core Values, Self-Honesty and Having Fun with Jairek Robbins, the New President of SUCCESS

“You gotta answer your DMs, man,” says Jairek Robbins, half laughing, in his latest Brilliant Thoughts interview with Tristan Ahumada. Robbins, who is an acclaimed business coach, best-selling author and ... Read more »

Surging Earnings Estimates Signal Upside for Xilinx (XLNX) Stock

Investors might want to bet on Xilinx (XLNX), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and ... Read more »

BCB Bancorp (BCBP) is a Top Dividend Stock Right Now: Should You Buy?

Whether it’s through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you’re an income investor, your primary focus is ... Read more »

The Zacks Analyst Blog Highlights: AbbVie, Merck, Eli Lilly, Novartis and Pfizer

For Immediate Release Chicago, IL – February 7, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ... Read more »

BankUnited (BKU) Stock up 3.4% on New Share Repurchase Plan

BankUnited, Inc. BKU has announced a new share repurchase plan. The company’s board of directors has approved the repurchase of up to $150 million in shares of BKU’s outstanding stock. ... Read more »